Catalyst Pharmaceutical Partners (CPRX) PT Lowered to $15 at Roth/MKM
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.49 --0%
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 14
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 14
Join SI Premium – FREE
Roth/MKM analyst Scott Henry lowered the price target on Catalyst Pharmaceutical Partners (NASDAQ: CPRX) to $15.00 (from $16.25) while maintaining a Neutral rating.
You May Also Be Interested In
- Nomura/Instinet Downgrades China Literature (772:HK) (CHLLF) to Neutral
- Chubu Electric Power Company (9502:JP) (CHUEF) PT Raised to JPY3,130 at Nomura/Instinet
- Intuitive Machines Inc. (LUNR) PT Lowered to $39 at Canaccord
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
